Platelet Inhibition Related to the Risk of Ischemic and Bleeding Events
{"Image DocumentName": "Platelet Inhibition Related to the Risk of Ischemic and Bleeding Events", "Image ImageDescription": "High risk of ischemic events. High risk of bleeding events. Sweet spot Risk of Any Event. Risk of Any Event. \u2013 Inhibition of platelet aggregation. + Ischemic risk. Bleeding risk. Ferreiro JL et al. Thromb Haemost. 2010;103: The CURE Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345: Plavix\u00ae (clopidogrel bisulfate) Prescribing Information. 58.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}